🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

16+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 16 of 16 recruiting trials for “Hereditary retinoblastoma”

RecruitingNCT06725173 ↗

Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.

👨‍⚕️ Debarshi Mustafi, MD PhD, University of Washington📍 1 site📅 Started Mar 2026View details ↗
EARLY_Phase 1RecruitingNCT06972602 ↗

High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed

🏥 Eye & ENT Hospital of Fudan University📍 1 site📅 Started Apr 2025View details ↗
Phase 2RecruitingNCT06679634 ↗

Retinoblastoma Phase II Expanded Access Clinical Trial

🏥 Targeted Therapy Technologies, LLC📍 1 site📅 Started Feb 2025View details ↗
EARLY_Phase 1RecruitingNCT06424301 ↗

Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma

👨‍⚕️ Chen Zhao, MD, Fudan Eye & ENT Hospital📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT06367530 ↗

Trilateral Retinoblastoma: Incidence and Outcomes

👨‍⚕️ Marcus de Jong, MD PhD, Amsterdam UMC📍 1 site📅 Started Jan 2024View details ↗
Enrolling by InvitationNCT06227962 ↗

Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors

👨‍⚕️ Annette C. Moll, MD PhD, Amsterdam University Medical Center📍 1 site📅 Started Oct 2023View details ↗
Phase 2RecruitingNCT05504291 ↗

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

👨‍⚕️ Rachana Shah, Children's Oncology Group📍 20 sites📅 Started Nov 2022View details ↗
Phase 2, PHASE3RecruitingNCT04681417 ↗

Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome

👨‍⚕️ Livia LUMBROSO LE ROUIC, MD, Institut Curie📍 28 sites📅 Started Mar 2021View details ↗
Phase 3RecruitingNCT04799002 ↗

Topotecan and Melphalan for Retinoblastoma

👨‍⚕️ Huashen Yang, Sun Yat-sen University📍 1 site📅 Started Mar 2021View details ↗
Phase 3RecruitingNCT05080010 ↗

Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma

👨‍⚕️ Huasheng Yang, M.D, PHD, Zhongshan Ophthalmic Center, Sun Yat-sen University📍 1 site📅 Started Nov 2020View details ↗
RecruitingNCT04425434 ↗

Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma

👨‍⚕️ FOUSSEYNI Mr TRAORE, Dr;, AMCC AND GFAOP📍 7 sites📅 Started Nov 2020View details ↗
RecruitingNCT03932786 ↗

Studying Health Outcomes After Treatment in Patients With Retinoblastoma

👨‍⚕️ Debra Friedman, MD, Vanderbilt Medical Center📍 11 sites📅 Started Jan 2019View details ↗
RecruitingNCT03546387 ↗

Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients

👨‍⚕️ Vittoria Arslan Carlon, MD, Memorial Sloan Kettering Cancer Center📍 1 site📅 Started May 2018View details ↗
RecruitingNCT03267459 ↗

Can Pretreatment MRI be Used to Predict Intra-arterial Chemotherapy Response in Retinoblastoma?

👨‍⚕️ Augustin Lecler, MD, Fondation OPH A de Rothschild📍 1 site📅 Started Jan 2018View details ↗
RecruitingNCT04959097 ↗

RB Liquid Biopsy Biorepository

👨‍⚕️ Jesse L Berry, MD, Children's Hospital Los Angeles📍 1 site📅 Started Jan 2017View details ↗
RecruitingNCT01109394 ↗

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

👨‍⚕️ Rosandra N Kaplan, M.D., National Cancer Institute (NCI)📍 5 sites📅 Started Apr 2010View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →